NPI: 1013984533 · SOUTH DAYTONA, FL 32119 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 03/02/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 03/02/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 10,327 | $1.13M |
| 2019 | 13,151 | $1.39M |
| 2020 | 18,995 | $2.31M |
| 2021 | 10,851 | $751K |
| 2022 | 1,836 | $242K |
| 2023 | 472 | $86K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 18,229 | 1,249 | $2.04M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 15,328 | 700 | $1.41M |
| J1270 | Injection, doxercalciferol, 1 mcg | 12,458 | 800 | $1.22M |
| A4657 | Syringe, with or without needle, each | 2,202 | 1,036 | $400K |
| J1756 | Injection, iron sucrose, 1 mg | 2,908 | 593 | $317K |
| 85041 | 1,070 | 706 | $122K | |
| 85048 | 1,067 | 705 | $120K | |
| 83970 | 823 | 409 | $93K | |
| 83540 | 444 | 292 | $52K | |
| 82728 | 400 | 281 | $44K | |
| 83550 | 399 | 280 | $44K | |
| 82108 | 200 | 156 | $29K | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 15 | 12 | $5K |
| 82607 | 13 | 13 | $4K | |
| G0008 | Administration of influenza virus vaccine | 26 | 17 | $3K |
| 82746 | 12 | 12 | $3K | |
| 90674 | 17 | 12 | $3K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 21 | 12 | $1K |